切换至 "中华医学电子期刊资源库"

中华心脏与心律电子杂志 ›› 2017, Vol. 05 ›› Issue (01) : 7 -11. doi: 10.3877/cma.j.issn.2095-6568.2017.05.002

所属专题: 文献

论著

心率减速力、体表心电图V1导联f波平均振幅及超敏C反应蛋白与心房颤动射频消融术后复发的相关性研究
宋玮1, 周发展1, 闫文菊1, 郭忠秀1, 丰伟2, 张焕轶1,()   
  1. 1. 271000 泰安,山东省泰安市中心医院心内科
    2. 271000 泰安,山东省泰安市中心医院消化内科
  • 出版日期:2017-03-25
  • 通信作者: 张焕轶

Correlation study of deceleration capacity of heart rate, fibrillatory wave amplitude on lead V1 of surface electrocardiography, hsCRP and recurrence of atrial fibrillation after radiofrequency catheter ablation

Wei Song1, Fazhan Zhou1, Wenju Yan1, Zhongxiu Guo1, Wei Feng2, Huanyi Zhang1,()   

  1. 1. Depatrment of Cardiology, Taian City Center Hospital, Taian 271000, China
    2. Depatrment of gastroenterology, Taian City Center Hospital, Taian 271000, China
  • Published:2017-03-25
  • Corresponding author: Huanyi Zhang
  • About author:
    Corresponding author: Zhang Huanyi, Email:
引用本文:

宋玮, 周发展, 闫文菊, 郭忠秀, 丰伟, 张焕轶. 心率减速力、体表心电图V1导联f波平均振幅及超敏C反应蛋白与心房颤动射频消融术后复发的相关性研究[J]. 中华心脏与心律电子杂志, 2017, 05(01): 7-11.

Wei Song, Fazhan Zhou, Wenju Yan, Zhongxiu Guo, Wei Feng, Huanyi Zhang. Correlation study of deceleration capacity of heart rate, fibrillatory wave amplitude on lead V1 of surface electrocardiography, hsCRP and recurrence of atrial fibrillation after radiofrequency catheter ablation[J]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2017, 05(01): 7-11.

目的

探讨心率减速力(DC)、体表心电图V1导联f波平均振幅、超敏C反应蛋白(hsCRP)与心房颤动(AF)患者射频消融术后复发的相关性。

方法

选取2015年6月至2016年8月因AF在泰安市中心医院住院并首次行射频消融术患者70例,根据术后随访结果分为未复发组45例,复发组25例。统计两组患者一般资料、DC值、体表心电图V1导联f波平均振幅及hsCRP并进行比较,建立Logistic回归模型,筛选AF患者射频消融术后复发的危险因素,分别对DC值、体表心电图V1导联f波平均振幅、hsCRP及两两联合、三者联合进行受试ROC曲线绘制,评价三者对AF术后复发的预测价值。

结果

复发组患者DC值(5.78±0.99)ms、hsCRP(1.85±0.77)mg/L高于未复发组(4.93±0.95)ms、(1.39±0.61)mg/L,体表心电图V1导联f波平均振幅(0.095±0.013)mV小于未复发组(0.110±0.017)mV,差异均有统计学意义(均P<0.05);经多因素Logistic回归分析显示,DC(OR=3.99,95%CI:1.36~11.68,P=0.012)、体表心电图V1导联f波平均振幅(OR=0.000,95%CI:0.000~0.000,P=0.013)、hsCRP(OR=5.15,95%CI:1.11~23.78,P=0.036)是AF患者射频消融术后复发的独立危险因素;DC值、体表心电图V1导联f波平均振幅、hsCRP预测AF术后复发ROC曲线下面积分别为0.731、0.741、0.667,三者联合预测AF射频消融术后复发曲线下面积为0.837,高于各自值及两两联合(P<0.05)。

结论

DC、体表心电图V1导联f波平均振幅及hsCRP与AF射频消融术后复发具有显著相关性,联合检测三者对预测AF射频消融术后复发具有重要临床价值。

Objective

To investigate the correlation between deceleration capacity of heart rate(DC), fibrillatory wave amplitude on lead V1 of surface electrocardiography, hsCRP and recurrence after radiofrequency ablation in patients with atrial fibrillation(AF).

Methods

Select the 70 AF patients who was operated with radio frequency catheter ablation for the first time from June 2015 to August 2016.According to the follow-up results, 45 cases were divided into the non-recurrence group and 25 cases in the recurrence group.General information, DC values, fibrillatory wave amplitude on lead V1 of surface electrocardiography, hsCRP of the two groups were collected and compared, establish Logistic regression model, screening of risk factors for AF patients after radiofrequency catheter ablation.DC values, fibrillatory wave amplitude on lead V1 of surface electrocardiography , hsCRP and the combination of the two, the combination of the three subjects were drawn the Receiver operating curve(ROC), to evaluate the predictive value of the combination of the three on the recurrence of the AF patients who was operated with radio frequency catheter ablation.

Results

The DC value(5.78±0.99)ms and hsCRP(1.85±0.77)mg/L in the recurrence group was higher than that in the non recurrence group(4.93±0.95)ms、(1.39±0.61)mg/L. The fibrillatory wave amplitude on lead V1 of surface electrocardiography in the recurrence group(0.095±0.013) mV was less than non recurrence group(0.110±0.017)mV(P<0.05). Multivariate Logistic regression analysis showed that the DC value(OR=3.99, 95%CI: 1.36-11.68, P=0.012), fibrillatory wave amplitude on lead V1 of surface electrocardiography(OR=0.000, 95%CI: 0.000-0.000, P=0.013), hsCRP(OR=5.15, 95%CI: 1.11-23.78, P=0.036)are independent risk factor for recurrence after radiofrequency ablation in patients with AF.The ROC curves of DC, fibrillatory wave amplitude on lead V1 of surface electrocardiography and hsCRP showed AUC were 0.731, 0.741 and 0.667. The ROC curves of combination of the three subjects showed AUC was 0.837, higher than their respective and the combination of the two values (P<0.05).

Conclusion

DC values, fibrillatory wave amplitude on lead V1 of surface electrocardiography and hsCRP had significant correlation with the recurrence of atrial fibrillation after adiofrequency catheter ablation. three combinations had predictive value in atrial AF patients who recurrent after radiofrequency catheter ablation.

表1 未复发组与复发组基本资料比较
表2 AF术后复发因素的多因素Logistic回归分析结果
表3 DC、体表心电图V1导联f波平均振幅及hsCRP对AF射频消融术后复发的预测价值
[1]
Disertori M, Lombardi F, Barlera S, et al. Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial[J]. American Heart Journal, 2010, 159(5): 857-863.
[2]
周自强,胡大一,陈捷,等.中国心房颤动现状的流行病学研究[J]. 中华内科杂志,2004, 43(7):491-494.
[3]
宋学莲,党懿,齐晓勇.心房颤动经射频消融术后复发因素的研究进展[J]. 中国心血管病研究,2015, 13(4):298-302.
[4]
Wei W, Ge JB, Zou Y, et al. Anatomical characteristics of pulmonary veins for the prediction of postoperative recurrence after radiofrequency catheter ablation of atrial fibrillation[J]. Plos One, 2014, 9(4): e93817.
[5]
Kalil C, Bartholomay E, Borges A, et al. Atrial fibrillation ablation by use of electroanatomical mapping: efficacy and recurrence factors[J]. Arquivos Brasileiros De Cardiologia, 2014, 11(2): 30-38.
[6]
Scherlag BJ, Yamanashi WS, Schauerte P, et al. Endovascular stimulation within the left pulmonary artery to induce slowing of heart rate and paroxysmal atrial fibrillation[J]. Cardiovasc Res, 2002, 54(2): 470-475.
[7]
郭继鸿.猝死预警新技术:连续心率减速力测定[J]. 临床心电学杂志,2012, 21(3):227-233.
[8]
余敏. F波振幅对持续性房颤射频消融术后复发预测价值研究[D]. 北京:北京协和医学院,2012.
[9]
Roithinger FX, SippensGroenewegen A, Karch MR, et al.Organized activation during atrial fibrillation in man: endocardial and electrocadiographic manifestations[J]. J Cardiovasc Electrophysiol, 1998, 9(5): 451-461.
[10]
4Th ET, Olgin JE. Basic mechanisms of atrial fibrillation[J]. Cardiology Clinics, 2004, 22(1): 9-20.
[11]
Hsu NW, Lin YJ, Tai CT, et al. Frequency analysis of the fibrillatory activity from surface ECG lead V1 and intracardiac recordings: implications for mapping of AF[J]. Europace, 2008, 10(4): 438-443.
[12]
Goudis CA, Kallergis EM, Vardas PE. Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation[J]. Europace, 2012, 14(5): 623-630.
[13]
Eckstein J, Verheule S, de Groot NM, et al. Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria[J]. Prog Biophys Mol Biol, 2008, 97(2-3): 435-451.
[14]
Kornej J, Reinhardt C, Kosiuk J, et al. Response of High-Sensitive C-Reactive Protein to Catheter Ablation of Atrial Fibrillation and Its Relation with Rhythm Outcome[J]. Plos One, 2011, 7(8): e44165.
[15]
Nishino M, Mori N, Nakamura D, et al. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation[J]. J Cardiol, 2013, 62(2): 117-120.
[16]
Sotomi Y, Inoue K, Ito N, et al. Incidence and risk factors for very late recurrence of atrial fibrillation after radiofrequency catheter ablation[J]. Europace, 2013, 15(11): 1581-1586.
[1] 刘丹妮, 敖梦, 冉海涛, 李世玉, 秦芳. 三维超声心动图及二维斑点追踪成像对持续性心房颤动复律后双心房逆向重构的评估[J]. 中华医学超声杂志(电子版), 2023, 20(08): 827-835.
[2] 涂鹏, 张晓航, 董虹美, 陈功立, 冉素真. 超声多普勒评估在双胎输血综合征射频消融减胎术后的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(05): 492-497.
[3] 王兴, 张峰伟. 腹腔镜肝切除联合断面射频消融治疗伴微血管侵犯肝细胞癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 580-583.
[4] 宋铭杰, 韩青雷, 李佳隆, 邵英梅. 内镜下晚期肝外胆管恶性肿瘤消融治疗研究现况[J]. 中华普外科手术学杂志(电子版), 2023, 17(03): 340-342.
[5] 刘立, 陈诚, 李新科, 刘凯, 屠昌明. 血清IL-6、hs-CRP、MMP-9联合检测在腹股沟疝无张力修补术预后评价中的价值分析[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 405-409.
[6] 李海明, 刘鸿飞, 李俊. 血清脂蛋白酶水平与COPD患者骨骼肌质量减少的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 500-503.
[7] 芦丹, 杨硕, 刘旭. VEGF、HMGB1、hs-CRP/Alb在AECOPD伴呼吸衰竭中的变化及预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 532-534.
[8] 张海涛, 贾哲, 马超, 张其坤, 武聚山, 郭庆良, 曾道炳, 栗光明, 王孟龙. 手术切除与射频消融治疗血管周围型单发小肝癌临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 523-527.
[9] 孟泓宇, 卢逸, 曹彦龙, 戴操, 杨佳伟, 林楠, 徐见亮. 基于PSM比较TACE联合射频消融与单纯射频消融治疗小肝癌疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 417-421.
[10] 于雁宾, 党受琴, 庄云龙, 许世友, 孟令展, 俞鹏, 高远, 李虎, 曹李, 朱震宇. 35例肝血管平滑肌脂肪瘤患者诊治及疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 327-330.
[11] 王震, 杨晓月, 苏康康, 王朝阳, 李少杰, 陈淑霞, 谷剑. β受体阻滞剂对心力衰竭合并房颤患者预后影响的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(04): 479-482.
[12] 曹宾, 郭瑛, 夏盼盼, 刘佳榛, 王骏, 孙育民. 非阵发性心房颤动的治疗策略:来自心脏电生理一线医师的问卷调查[J]. 中华心脏与心律电子杂志, 2023, 11(03): 147-153.
[13] 段园霞, 顾柳娜, 张磊, 周丽婷, 朱海瀛, 杨超, 陈海英, 顾晓青, 高宗尚, 黄蛟灵. 上海市奉贤区基层全科医师对心房颤动的认知现状及影响因素分析[J]. 中华心脏与心律电子杂志, 2023, 11(03): 154-159.
[14] 范家宁, 林大卫, 李明飞, 张峰, 张晓春, 潘文志, 周达新. 左心耳封堵术联合房间隔缺损封堵术一站式手术安全性与有效性研究[J]. 中华心脏与心律电子杂志, 2023, 11(02): 109-113.
[15] 邱令智, 胡萍, 罗婷, 鄢华. 脂蛋白(a)与心房颤动关系的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 280-284.
阅读次数
全文


摘要